Hantz Financial Services Inc. Increases Stock Position in Intuitive Surgical, Inc. $ISRG

Hantz Financial Services Inc. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,592 shares of the medical equipment provider’s stock after purchasing an additional 652 shares during the period. Hantz Financial Services Inc.’s holdings in Intuitive Surgical were worth $8,473,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares in the last quarter. Golden State Wealth Management LLC lifted its position in shares of Intuitive Surgical by 13.7% in the first quarter. Golden State Wealth Management LLC now owns 1,757 shares of the medical equipment provider’s stock valued at $870,000 after acquiring an additional 212 shares in the last quarter. Ameritas Advisory Services LLC lifted its holdings in Intuitive Surgical by 5.9% in the 1st quarter. Ameritas Advisory Services LLC now owns 1,724 shares of the medical equipment provider’s stock valued at $878,000 after purchasing an additional 96 shares in the last quarter. Rossby Financial LCC purchased a new position in Intuitive Surgical in the 1st quarter valued at about $101,000. Finally, FSM Wealth Advisors LLC lifted its holdings in Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after purchasing an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.4%

Shares of ISRG opened at $530.02 on Friday. The stock’s fifty day simple moving average is $463.16 and its 200 day simple moving average is $498.23. The firm has a market capitalization of $190.00 billion, a P/E ratio of 70.11, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period last year, the business posted $1.84 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 7,562 shares of the firm’s stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $193,595.79. This trade represents a 95.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 96,011 shares of company stock valued at $50,309,042 in the last three months. 0.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ISRG. Piper Sandler upped their price objective on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Jefferies Financial Group increased their price target on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. The Goldman Sachs Group increased their price target on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Argus increased their target price on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday. Finally, Leerink Partners increased their target price on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.